Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
|
| gptkbp:activeIngredient |
gptkb:pseudoephedrine
|
| gptkbp:alternativeActiveIngredient |
gptkb:phenylephrine
|
| gptkbp:alternativeTo |
gptkb:Sudafed_PE
|
| gptkbp:category |
decongestant
sympathomimetic amine |
| gptkbp:contraindication |
hypertension
severe coronary artery disease |
| gptkbp:countryOfOrigin |
gptkb:United_States
|
| gptkbp:form |
gptkb:tablet
gptkb:water |
| https://www.w3.org/2000/01/rdf-schema#label |
Sudafed
|
| gptkbp:introducedIn |
1970s
|
| gptkbp:legalStatus |
restricted OTC (US)
|
| gptkbp:manufacturer |
gptkb:Johnson_&_Johnson
|
| gptkbp:OTC |
yes
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionRequired |
no (with restrictions in some regions)
|
| gptkbp:regulates |
yes
|
| gptkbp:regulationReason |
precursor to methamphetamine
|
| gptkbp:sideEffect |
nervousness
insomnia increased blood pressure |
| gptkbp:storage |
room temperature
|
| gptkbp:usedFor |
nasal congestion
|
| gptkbp:website |
https://www.sudafed.com/
|
| gptkbp:bfsParent |
gptkb:Warner-Lambert
gptkb:Johnson_&_Johnson_Consumer_Inc. |
| gptkbp:bfsLayer |
6
|